Free 15% Customization On All Syndicated Reports.

Global Clinical Nutrition Market : Child consumers segment is expected to account for higher market share of more than 55% driven due to rising birth of premature babies : Global Market Analysis 2013 – 2017 and Forecast 2018 – 2024

Market Scenario

Global Clinical Nutrition Market is likely to grow at CAGR of around 6% and will exceed over USD 51.0 billion by 2024. Global Clinical Nutrition Market growth is primarily driven by rising adoption of nutritional products by both children and adults. Other factors including increasing population, decreased amount of minerals, vitamins and other nutrition’s in the food which is consumed also drive the market for clinical nutrition through the forecast period. Global Clinical Nutrition Market Overview, By Region North America had the highest market share in 2016 due to the factors such as, increased unhealthy food consumption, increasing number of people suffering from the chronic diseases, rising home care, and decreasing physical activities drive the market clinical nutrition through the forecast period. Increasing inability in the children to absorb the nutrients due to improper diet also drive the clinical nutrition market in this region. Global Clinical Nutrition Market Overview, By Consumers Global Clinical Nutrition Market Global Clinical Nutrition Market had the highest share in 2016. Global Clinical Nutrition Market is driven due to rising birth of premature babies, increasing inability in the children to absorb the nutrients due to improper diet, rising number of working women’s, and urbanisation-that provide high demand for infant nutrition. Other factors such as, increasing metabolic syndromes among children’s, advanced healthcare facilities for children’s, and increasing incidences of lifestyle related diseases also drive the market for clinical nutrients in the child consumer segment. Global Clinical Nutrition Market Overview, By Products Infant nutrition segment had the highest market share in 2016. The factors such as, increasing number of malnourished babies, rising awareness about the products, due to government programs, that help to understand about the products advantages drive the market for infant nutrition market through the forecast period. Global Clinical Nutrition Market Overview, By Market Players Increasing healthcare expenditure by all the regions also drive the market for Clinical Nutrition through the forecast period. Some of the companies operating in Global Clinical Nutrition Market are Ajinomto Co. Inc., Fresenius Kabi AG, Hero Nutritional Inc., Perrigo Company Plc., Abbott nutrition Inc., and Baxter International Inc. Global Clinical Nutrition Market Background Developing countries such as China, and India are increasing their investments for the healthcare sectors. Other private organizations in the developing countries also investing on the healthcare infrastructures. These factors drive the Global Clinical Nutrition Market through the forecast period.

Global Clinical Nutrition Market Segmentation

Global Clinical Nutrition Market , By Products

o Infant Nutrition  Milk-based  Organic  Soy-based  Others o Parental Nutrition o Enteral Nutrition  Standard  Chronic Illness

• Global Clinical Nutrition Market, By Consumer

o Child o Adult The above data will be provided for following regions/countries from 2013-2024 (USD Million) • North America o U.S. o Canada • Europe o Germany o UK o France o Spain o Italy • Asia Pacific o China o India o Japan o Australia • Latin America o Argentina o Brazil o Mexico • Middle East and Africa o South Africa o Saudi Arabia What information is covered in report? • Actual market numbers from 2013-2017, estimates and forecasts from 2018 to 2024 • Detailed market segmentation and market share analysis of each segment • Impact analysis of various drivers and trends • Market segmentation and landscape • Competitive landscape, 2017. Global Cochlear Implant Systems Market  

Table of Contents

Global Clinical Nutrition Market

Chapter 1 Research Methodology .1.1. Research Methodology .1.2. Market definition .1.3. Assumptions and Acronyms Used .1.4. Data Sources .1.4.1. Secondary .1.4.1.1. Paid .1.4.1.2. Unpaid .1.4.2. Primary Chapter 2 Executive Summary .2.1. Global Clinical Nutrition Market overview .2.1.1. By Products .2.1.2. By Consumer Chapter 3 Global Clinical Nutrition Market Industry Insights .3.1. Market segmentation and scope of study .3.2. Market Drivers and their impact analysis .3.2.1. Market Drivers .3.2.1.1. Rising incidences of enfeebling diseases .3.2.2. Market Restraints .3.2.2.1. Stringent regulations pertaining to clinical nutrition solutions .3.3. Market share analysis .3.3.1. By Products .3.3.2. By Consumer .3.4. Competitive analysis .3.4.1. Key strategic initiatives .3.4.2. Regional presence .3.4.3. Product overview .3.5. Porter’s analysis .3.6. PESTEL analysis Chapter 4 Clinical Nutrition Market, By Products .4.1. Key segment trends .4.2. Infant Nutrition .4.2.1. Market size, by region, 2013 - 2024 .4.3. Milk-based .4.3.1. Market size, by region, 2013 – 2024 .4.4. Organic .4.4.1. Market size, by region, 2013 – 2024 .4.5. Soy-based .4.5.1. Market size, by region, 2013 – 2024 .4.6. Others .4.6.1. Market size, by region, 2013 – 2024 .4.7. Parental Nutrition .4.7.1. Market size, by region, 2013 – 2024 .4.8. Enteral Nutrition .4.8.1. Market size, by region, 2013 – 2024 .4.9. Standard .4.9.1. Market size, by region, 2013 – 2024 .4.10. Chronic Illness .4.10.1. Market size, by region, 2013 – 2024 Chapter 5 Clinical Nutrition Market, By Consumer .5.1. Key segment trends .5.2. Child .5.2.1. Market size, by region, 2013 - 2024 .5.3. Adult .5.3.1. Market size, by region, 2013 – 2024 .5.4. Old .5.4.1. Market size, by region, 2013 – 2024 Chapter 6 Clinical Nutrition Market, By Region .6.1. Key regional trends .6.2. North America .6.2.1. Market size, by country, 2013 – 2024 .6.2.2. Market size, by products, 2013 – 2024 .6.2.3. Market size, by consumer, 2013 – 2024 .6.3. U.S. .6.3.1. Market size, by products, 2013 – 2024 .6.3.2. Market size, by consumer, 2013 – 2024 .6.4. Canada .6.4.1. Market size, by products, 2013 – 2024 .6.4.2. Market size, by consumer, 2013 – 2024 .6.5. Europe .6.5.1. Market size, by country, 2013 – 2024 .6.5.2. Market size, by products, 2013 – 2024 .6.5.3. Market size, by consumer, 2013 – 2024 .6.6. Germany .6.6.1. Market size, by products, 2013 – 2024 .6.6.2. Market size, by consumer, 2013 – 2024 .6.7. UK .6.7.1. Market size, by products, 2013 – 2024 .6.7.2. Market size, by consumer, 2013 – 2024 .6.8. France .6.8.1. Market size, by products, 2013 – 2024 .6.8.2. Market size, by consumer, 2013 – 2024 .6.9. Spain .6.9.1. Market size, by products, 2013 – 2024 .6.9.2. Market size, by consumer, 2013 – 2024 .6.10. Italy .6.10.1. Market size, by products, 2013 – 2024 .6.10.2. Market size, by consumer, 2013 – 2024 .6.11. Sweden .6.11.1. Market size, by products, 2013 – 2024 .6.11.2. Market size, by consumer, 2013 – 2024 .6.12. Asia Pacific .6.12.1. Market size, by country, 2013 – 2024 .6.12.2. Market size, by products, 2013 – 2024 .6.12.3. Market size, by consumer, 2013 – 2024 .6.13. India .6.13.1. Market size, by products, 2013 – 2024 .6.13.2. Market size, by consumer, 2013 – 2024 .6.14. China .6.14.1. Market size, by products, 2013 – 2024 .6.14.2. Market size, by consumer, 2013 – 2024 .6.15. Japan .6.15.1. Market size, by products, 2013 – 2024 .6.15.2. Market size, by consumer, 2013 – 2024 .6.16. Australia .6.16.1. Market size, by products, 2013 – 2024 .6.16.2. Market size, by consumer, 2013 – 2024 .6.17. Latin America .6.17.1. Market size, by country, 2013 – 2024 .6.17.2. Market size, by products, 2013 – 2024 .6.17.3. Market size, by consumer, 2013 – 2024 .6.18. Argentina .6.18.1. Market size, by products, 2013 – 2024 .6.18.2. Market size, by consumer, 2013 – 2024 .6.19. Brazil .6.19.1. Market size, by products, 2013 – 2024 .6.19.2. Market size, by consumer, 2013 – 2024 .6.20. Mexico .6.20.1. Market size, by products, 2013 – 2024 .6.20.2. Market size, by consumer, 2013 – 2024 .6.21. Middle East and Africa .6.21.1. Market size, by country, 2013 – 2024 .6.21.2. Market size, by products, 2013 – 2024 .6.21.3. Market size, by consumer, 2013 – 2024 .6.22. South Africa .6.22.1. Market size, by products, 2013 – 2024 .6.22.2. Market size, by consumer, 2013 – 2024 .6.23. Saudi Arabia .6.23.1. Market size, by products, 2013 – 2024 .6.23.2. Market size, by consumer, 2013 – 2024 Chapter 7 Consolidations .7.1. Mergers and Acquisitions .7.2. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements .7.3. Patent Analysis Chapter 8 Company Profiles .8.1. Baxter International Inc. .8.1.1. Company overview .8.1.2. Key financials .8.1.3. Product landscape .8.1.4. Strategic initiatives .8.1.5. SWOT analysis .8.2. B. Braun Melsungen AG .8.2.1. Company overview .8.2.2. Key financials .8.2.3. Product landscape .8.2.4. Strategic initiatives .8.2.5. SWOT analysis .8.3. Groupe Danone .8.3.1. Company overview .8.3.2. Key financials .8.3.3. Product landscape .8.3.4. Strategic initiatives .8.3.5. SWOT analysis .8.4. Mead Johnson Nutrition Company .8.4.1. Company overview .8.4.2. Key financials .8.4.3. Product landscape .8.4.4. Strategic initiatives .8.4.5. SWOT analysis .8.5. Nestlé SA .8.5.1. Company overview .8.5.2. Key financials .8.5.3. Product landscape .8.5.4. Strategic initiatives .8.5.5. SWOT analysis .8.6. Hospira Inc .8.6.1. Company overview .8.6.2. Key financials .8.6.3. Product landscape .8.6.4. Strategic initiatives .8.6.5. SWOT analysis .8.7. Perrigo Company Plc .8.7.1. Company overview .8.7.2. Key financials .8.7.3. Product landscape .8.7.4. Strategic initiatives .8.7.5. SWOT analysis .8.8. Abbott Laboratories .8.8.1. Company overview .8.8.2. Key financials .8.8.3. Product landscape .8.8.4. Strategic initiatives .8.8.5. SWOT analysis .8.9. H. J. Heinz Company .8.9.1. Company overview .8.9.2. Key financials .8.9.3. Product landscape .8.9.4. Strategic initiatives .8.9.5. SWOT analysis .8.10. Fresenius Kabi AG .8.10.1. Company overview .8.10.2. Key financials .8.10.3. Product landscape .8.10.4. Strategic initiatives .8.10.5. SWOT analysis .8.11. Gentiva Health Services Inc. .8.11.1. Company overview .8.11.2. Key financials .8.11.3. Product landscape .8.11.4. Strategic initiatives .8.11.5. SWOT analysis .8.12. Hospira (Pfizer) Inc. .8.12.1. Company overview .8.12.2. Key financials .8.12.3. Product landscape .8.12.4. Strategic initiatives .8.12.5. SWOT analysis .8.13. Hero Nutritional Inc. .8.13.1. Company overview .8.13.2. Key financials .8.13.3. Product landscape .8.13.4. Strategic initiatives .8.13.5. SWOT analysis .8.14. Perrigo Company Plc. .8.14.1. Company overview .8.14.2. Key financials .8.14.3. Product landscape .8.14.4. Strategic initiatives .8.14.5. SWOT analysis

Inquiry Before Buying

Request Sample

About This Report

Report ID9839
Category Healthcare
Publisher Name
No of Pages
Total Views
Published Date
Contact Us
Call Now